Showing results (171-180 of 504) with videos related to
Sort By:
Pageof 51
European Heart Journal|May 27, 2010
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney diseaseHiddo J Lambers Heerspink, Toshiharu Ninomiya, Vlado Perkovic, et al.JACC. Heart Failure|November 3, 2019
Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 DiabetesJingWei Li, Mark Woodward, Vlado Perkovic, et al.International Journal of Cardiology|September 26, 2020
An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trialsJie Yu, Zien Zhou, Kenneth W Mahaffey, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 4, 2022
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosisVandana S Mathur, David A Bushinsky, Lesley Inker, et al.Nephrology (Carlton, Vic.)|June 6, 2020
No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trialBrendan Smyth, Li Zuo, Nicholas A Gray, et al.Pediatrics|April 3, 2004
A review of Internet-based home drug-testing products for parentsSharon Levy, Shari Van Hook, John KnightApplied and Environmental Microbiology|May 17, 2015
Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse ModelXingsheng Li, Melissa L Ellis, John KnightPopulation Health Management|February 18, 2010
The relationship among body mass index, subjective reporting of chronic disease, and the use of health care services in Newfoundland and Labrador, CanadaLaurie K Twells, John Knight, Reza AlaghehbandanJournal of the American Society of Nephrology : JASN|September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.Journal of the American Society of Nephrology : JASN|January 23, 2024
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic AcidosisNavdeep Tangri, Vandana S Mathur, David A Bushinsky, et al.Pageof 51